|
Market Cap (17-May) $14,687,399 (777th) |
Close (30-Jun) $0.018 |
Volume (30-Jun) 1,123,417 |
Shortsold (11-Sep) 1,800,000 (0.12%) (439th) |
|
52w High $0.000 |
52w Low $0.000 |
P/E 20.00 |
EPS -0.02 |
BNO released this announcement to the ASX on 11 November 2021, 17:43. The announcement is not marked as price sensitive, and is 2 page(s) in length and 159.37kb in size.
You can view all announcements from BNO and see how they appear on a price chart on the announcements page.
At the date of this announcement, BNO was 0.087% short sold according to ASIC data. It was ranked the 519th most shorted stock on the ASX. It is now ranked as the 439th most shorted stock on the ASX with 0.123% of total shares short sold as of the latest reported data (11 September 2023).
| Other Recent Announcements from BNO | |
|---|---|
| Poster Presentation at the ASCP Annual Meeting | 1 June 2023, 9:16 |
| Corporate Presentation - May 2023 | 23 May 2023, 9:24 |
| BNO announces establishment of At-The-Market Equity Program | 8 May 2023, 8:54 |
| Section 708A Notice | 11 November 2021, 17:43 |
| Application for quotation of securities - BNO | 11 November 2021, 17:01 |
| FDA Clears BNC210 Ph2 Social Anxiety Disorder IND (PREVAIL) | 1 November 2021, 10:02 |
| 2021 Notice of AGM/Proxy Form | 1 November 2021, 10:00 |
You must be logged in to post a reply.
Bionomics 